Ishwaria Subbiah: ASCO25 study – Exercise Significantly Boosts Survival for Colon Cancer Survivors
Ishwaria Subbiah, Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI), shared a post on LinkedIn:
“For the millions of colon cancer survivors worldwide, this ASCO25 study is the first definitive evidence that staying active could be lifesaving. Structured exercise:
- Reduces cancer recurrence risk
- Prevents new cancers
- Extends overall survival
Key Findings:
- Patients who participated in a 3-year structured exercise program had a **28% lower risk** of cancer recurrence, new cancers, or death compared to those who only received health education materials
- 5-year disease-free survival: 80.3% (exercise) vs 73.9% (control) – a meaningful 6.4% improvement
- 8-year overall survival: 90.3% (exercise) vs 83.2% (control) – a 7.1% advantage
The 15-year study published in NEJM was conducted across 55 medical centers, followed 889 patients who had completed treatment for resected colon cancer.
The exercise program was started soon after completing adjuvant chemotherapy.”
Title: Structured Exercise after Adjuvant Chemotherapy for Colon Cancer
Authors: Kerry Courneya, Janette Vardy, Christopher O’Callaghan, Sharlene Gill, Christine Friedenreich, Rebecca Wong, Haryana Dhillon, Victoria Coyle, Neil Chua, Derek Jonker, Philip Beale, Kamal Haider, Patricia Tang, Tony Bonaventura, Ralph Wong, Howard Lim, Matthew Burge, Stacey Hubay, Michael Sanatani, Kristin Campbell, Fernanda Arthuso, Jane Turner, Ralph Meyer, Michael Brundage, Patti O’Brien, Dongsheng Tu, Christopher Booth
Read the Full Article.
More posts featuring Ishwaria Subbiah on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023